Trending...
- Expanding Beyond Space as New Drone Market Opportunities Accelerate Growth: Ascent Solar Technologies (N A S D A Q: ASTI)
- Boston: Notice of Finding of No Significant Impact and Notice of Intent to Request Release of Funds - Hollins Park: August 7, 2026
- Lauren Merrell, Dale Sorensen Real Estate, announces price improvement for an extraordinary island retreat
FAYETTEVILLE, Ark. - BostonChron -- Lineus Medical is pleased to announce a new distribution agreement with DIMA MedTech, marking the company's entry into the Italian market and further expanding its growing presence across Europe after receiving CE mark in December of 2025. Through this agreement, DIMA MedTech will provide Lineus Medical with a local presence in Italy as well as support the introduction and expansion of SafeBreak Vascular throughout Italy.
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on an IV line, SafeBreak intentionally separates to remove the damaging force from the IV line and protect the patient's vascular access. Upon separation, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. The separated device causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile device is installed, and the patient's infusion is continued. SafeBreak Vascular is cleared for all vascular lines down to two weeks of age– delivering better outcomes for patients, efficiency for nurses, and cost savings for hospitals alike.1
More on Boston Chron
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks another significant milestone in Lineus Medical's international growth. By partnering with DIMA MedTech, we are beginning our commercialization strategy in Europe and continuing to build momentum for broader global adoption. DIMA MedTech's local expertise and established network make them the right partner to drive commercial success throughout Italy."
Vance Clement, CEO of Lineus Medical, stated, "Expanding into Italy is a meaningful step forward in our mission to remove the "pains" associated with medical lines. First came European regulatory clearance for our product, and next is the establishment of a robust European distribution network. DIMA MedTech is a terrific distributor in Italy and our first in Europe."
About Lineus Medical
Lineus Medical develops innovative medical technologies designed to improve patient safety and healthcare efficiency. Its flagship product, SafeBreak Vascular, is a breakaway device for IV lines that helps protect patients from accidental IV dislodgements and associated complications.1
More on Boston Chron
About DIMA MedTech
DIMA MedTech is an operational partner for international medical technology companies seeking to establish and grow their presence in Italy. The company provides regulatory support, nationwide distribution, technical assistance, and local market expertise through a flexible operational model designed to simplify healthcare market entry and expansion.
References:
SafeBreak Vascular is the only breakaway device for IV lines clinically proven to reduce multiple IV complications.1 When a harmful force is placed on an IV line, SafeBreak intentionally separates to remove the damaging force from the IV line and protect the patient's vascular access. Upon separation, valves on both ends of the device close, preventing medicine spills from the pump and blood loss from the patient. The separated device causes the IV pump to alarm, notifying the nursing staff to check on the patient. To replace SafeBreak, each component is unthreaded from the line, a new sterile device is installed, and the patient's infusion is continued. SafeBreak Vascular is cleared for all vascular lines down to two weeks of age– delivering better outcomes for patients, efficiency for nurses, and cost savings for hospitals alike.1
More on Boston Chron
- KT Medical Staffing Addresses the Questions Families Forget to Ask Before Bringing Private Nursing Care Home
- Private Autopsies Give Arizona Families Answers After Nursing Home and Care Facility Deaths
- OPUS Global Data Solutions Launches Food Trader Plus, Bringing Operational Control and Deal-Level Profit Visibility to Food Brokers
- Phinge CEO DeMaio Unveils Speech to Congress: User Data Sovereignty vs Tech Surveillance Capitalism, Asserting Foundational 2021 App-Less Patents & IP
- Michael Maertens Hired as Century Fasteners Corp. – Chief Financial Officer
Larry Hayes, Lineus Medical's Chief Commercial Officer, stated, "This agreement marks another significant milestone in Lineus Medical's international growth. By partnering with DIMA MedTech, we are beginning our commercialization strategy in Europe and continuing to build momentum for broader global adoption. DIMA MedTech's local expertise and established network make them the right partner to drive commercial success throughout Italy."
Vance Clement, CEO of Lineus Medical, stated, "Expanding into Italy is a meaningful step forward in our mission to remove the "pains" associated with medical lines. First came European regulatory clearance for our product, and next is the establishment of a robust European distribution network. DIMA MedTech is a terrific distributor in Italy and our first in Europe."
About Lineus Medical
Lineus Medical develops innovative medical technologies designed to improve patient safety and healthcare efficiency. Its flagship product, SafeBreak Vascular, is a breakaway device for IV lines that helps protect patients from accidental IV dislodgements and associated complications.1
More on Boston Chron
- Built to Last: Why BSI Is Among the Nation's Fastest-Growing Companies, and One of Its Best Places to Work
- Bent Danholm's The Architecture of Demand Reaches No. 2 in Amazon Real Estate Sales
- Contracting Resources Group Named to Inc. 5000 for the Ninth Time
- Mativa Diagnostics & UGenome AI Announce Strategic Partnership to Bring Precision to Maternal Health
- ImagineX Named to 2026 Inc. 5000 List of America's Fastest-Growing Private Companies
About DIMA MedTech
DIMA MedTech is an operational partner for international medical technology companies seeking to establish and grow their presence in Italy. The company provides regulatory support, nationwide distribution, technical assistance, and local market expertise through a flexible operational model designed to simplify healthcare market entry and expansion.
References:
- Data on File.
Source: Lineus Medical
Filed Under: Technology
0 Comments
Latest on Boston Chron
- Boston: Notice of Finding of No Significant Impact and Notice of Intent to Request Release of Funds - Hollins Park: August 7, 2026
- Autonomous Robotics Platform Expansion as Public Market Debut is Very Close: MBody AI Corp. (N A S D A Q: MBAI)
- Boston: Color Flows Honors History at Liberty Tree Plaza
- Boston: Archaeologists Unearth New Clues at the Battle of Bunker Hill Site
- Boston: A New Chapter for the Blackstone Block
- Boston: Council Supports Allowing Retired Police Officers to Work Paid Details
- Boston: Council Urges City to Oppose Proposed ICE Parking Leases
- Recognizing the Contributions of Boston's Jamaican and Dominican Communities
- Council Recognizes Community Resources Supporting Health and Well-Being Across Boston
- Boston: Teen Dating Violence Awareness
- Boston: Council Calls for Critical-Incident Administrative Leave Standards Following In-Custody Death of Shacoby Kenny
- Loud! OOH calls for prize draw advertising standards as £1.3bn category moves outdoors
- Black Ribbon Productions Launches With Fearless 2026 Horror Slate
- Actor Dominic Pace Returns to Television and Film
- City of Boston Announces Rare Gravestone of Free Black Bostonian Rediscovered In Granary Burying Ground
- Demand Spring Welcomes Lucian Lui as Senior CMO Advisor
- Opteamix welcomes Girish Ramachandra to its leadership team as Senior Vice President of Client Services
- Mayor Michelle Wu Urges Caution As City of Boston Issues Heat Advisory
- Boston: July 2026 Mayor's Office of Housing Newsletter
- Silicon Box Ships 500M Units at High Yield, Expands Production Capacity for Panel-Level Packaging


